E2F1 and c-Myc drive the expression of miR92a-3p in HCC by directly binding to the promoter of miR17HG, the host gene of miR-92a-3p, thus promoting the progression of HCC. This evidence concerns the gene E2F1 and hepatocellular carcinoma.